Abstract 1357: Inhibition of breast cancer cell growth by a synthetic ligand targeting the nuclear receptor, REV-ERB (NR1D1 and NR1D2)
Year: 2011
Type: conference-abstract
Source: Cancer Research
Authors: Yongjun Wang, Theodore Kamenecka, Douglas Kojetin, Thomas P. Burris
Institution: Scripps Research Institute
Language: English
Subfield: Endocrine and Autonomic Systems
Field: Neuroscience
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2067023306